Cannabis Use Linked to Lower Methadone Blood Levels in Opioid Treatment
Among patients in methadone maintenance treatment, cannabis users had significantly lower methadone blood levels than non-users even after adjusting for dose, which could affect treatment effectiveness.
Quick Facts
What This Study Found
Researchers measured blood levels of the active form of methadone (l-methadone) in 94 opioid-dependent patients on maintenance treatment. They found that above 200 ng/ml, no patients reported heroin use, and above 250 ng/ml, craving was absent.
A key secondary finding was that cannabis users had significantly lower plasma l-methadone concentrations compared to non-users, even after adjusting for methadone dosage. This suggests a pharmacokinetic interaction where cannabis may accelerate methadone metabolism.
Other protective factors against heroin use included older age, stable employment, and being married.
Key Numbers
94 patients; above 200 ng/ml l-methadone: no heroin use; above 250 ng/ml: no craving; 54.2% achieved 100-250 ng/ml at doses of 60+ mg/day; cannabis users had significantly lower l-methadone levels (p<0.05)
How They Did This
Cross-sectional study of 94 consecutively recruited patients in methadone maintenance. Blood was drawn for l-methadone concentration, and urine analyses over the prior three weeks determined treatment response. Cannabis use was documented alongside demographic and dosing data.
Why This Research Matters
If cannabis use lowers methadone blood levels, it could reduce methadone treatment effectiveness and contribute to continued opioid use. This has practical implications for dosing decisions in patients who also use cannabis.
The Bigger Picture
Drug interactions between cannabis and medications are an increasingly important clinical concern. This finding suggests clinicians managing methadone treatment should consider cannabis use when adjusting doses, though the mechanism needs further study.
What This Study Doesn't Tell Us
Cross-sectional design cannot establish causation. Small sample. Cannabis use was self-reported. The mechanism for lower methadone levels was not determined. Could reflect differences in metabolism, adherence, or other unmeasured factors.
Questions This Raises
- ?Does cannabis actually accelerate methadone metabolism?
- ?Would dose adjustments in cannabis-using patients improve treatment outcomes?
- ?Is this interaction specific to methadone or does it affect other opioid medications?
Trust & Context
- Key Stat:
- Above 200 ng/ml l-methadone: zero heroin use reported
- Evidence Grade:
- Small cross-sectional study identifying an association. Important clinical observation but requires replication and mechanistic investigation.
- Study Age:
- Published in 2015. Cannabis-drug interactions remain under-studied in addiction medicine.
- Original Title:
- Relationship between plasma concentrations of the l-enantiomer of methadone and response to methadone maintenance treatment.
- Published In:
- European journal of pharmacology, 760, 1-6 (2015)
- Authors:
- Meini, Milo, Moncini, Marco, Daini, Laura, Giarratana, Tania, Scaramelli, Daniela, Chericoni, Silvio, Stefanelli, Fabio, Rucci, Paola
- Database ID:
- RTHC-01015
Evidence Hierarchy
A snapshot of a population at one point in time.
What do these levels mean? →Frequently Asked Questions
Does cannabis interfere with methadone treatment?
This study found that cannabis users had lower methadone blood levels, which could reduce treatment effectiveness. The mechanism is unclear but may involve cannabis affecting how the body metabolizes methadone.
What methadone blood level is needed for treatment to work?
The study found that above 200 ng/ml of l-methadone, no patients used heroin, and above 250 ng/ml, craving was absent. However, only about 54% of patients on adequate doses (60+ mg/day) achieved levels in the 100-250 ng/ml range.
Read More on RethinkTHC
- CBD-oil-quality-guide
- anxiety-medication-after-quitting-weed
- cannabis-chemotherapy-nausea
- cannabis-chronic-pain-research
- cannabis-epilepsy-CBD-Epidiolex
- cbd-anxiety-research-evidence
- cbd-for-weed-withdrawal
- cbd-vs-thc-difference
- medical-benefits-of-cannabis
- quitting-weed-before-surgery
- quitting-weed-medication-interactions
- quitting-weed-pregnancy
- quitting-weed-pregnant
- seniors-older-adults-cannabis-risks-medications
- weed-breastfeeding-THC-breast-milk
Cite This Study
https://rethinkthc.com/research/RTHC-01015APA
Meini, Milo; Moncini, Marco; Daini, Laura; Giarratana, Tania; Scaramelli, Daniela; Chericoni, Silvio; Stefanelli, Fabio; Rucci, Paola. (2015). Relationship between plasma concentrations of the l-enantiomer of methadone and response to methadone maintenance treatment.. European journal of pharmacology, 760, 1-6. https://doi.org/10.1016/j.ejphar.2015.03.081
MLA
Meini, Milo, et al. "Relationship between plasma concentrations of the l-enantiomer of methadone and response to methadone maintenance treatment.." European journal of pharmacology, 2015. https://doi.org/10.1016/j.ejphar.2015.03.081
RethinkTHC
RethinkTHC Research Database. "Relationship between plasma concentrations of the l-enantiom..." RTHC-01015. Retrieved from https://rethinkthc.com/research/meini-2015-relationship-between-plasma-concentrations
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.